(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010Liz Krutoholow, Specialty Pharma and Biotech Analyst for Bloomberg Intelligence, on the statements in Valeant's annual report filed today.
Bloomberg Intelligence
3,286 clip(s)
Intel Shares Fall on Report Nvidia Halts Production Test
Novo Nordisk Gets US Approval for Wegovy Obesity Pill
Larry Ellison’s Guarantee Ups Warner Bros. Stakes to a New Level